NCT06979141View on ClinicalTrials.gov

Dexmedetomidine, Magnesium Sulphate and Lidocaine for Cough Suppression After General Anesthesia

PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 2, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

August 1, 2026

Conditions
Cough
Interventions
DRUG

Dexmedetomidine

Patients will receive 0.5 μg/kg dexmedetomidine in 10ml normal saline 10 min before the end of surgery.

DRUG

Magnesium sulfate

Patients will receive 30 mg/kg IV magnesium sulfate 50% 10 min before the end of surgery.

DRUG

Lidocaine

Patients will receive lidocaine 1.5 mg/kg lidocaine 10 min before the end of surgery.

DRUG

normal saline

Patients will receive 10 ml normal saline 10 min before the end of surgery.

Trial Locations (1)

2091110

RECRUITING

Faculty of Medicine, Al-Azhar university Assiut, Egypt., Asyut

All Listed Sponsors
lead

Al-Azhar University

OTHER